Skip to content

Anti-MDA5 Antibody (Serum) – Qualitative/Quantitative Line Blot Assay

Published: August 9, 2026Updated: August 16, 2026

This test detects the presence of antibodies against the MDA5 protein, which may help diagnose certain inflammatory or autoimmune conditions affecting the lungs or skin.

Quick summary

["This test may be used to identify rare inflammatory diseases linked to specific antibody patterns."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
88725-7
Short code
MDA5 Ab Ser Line blot-aCnc
Synonyms
MDA5 Ab Ser Line blot-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
line-blot
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The MDA5 protein is involved in immune responses, particularly in detecting viral infections. When the body produces antibodies against MDA5, it may signal an autoimmune reaction or an inflammatory process. This test uses a line blot assay to identify these antibodies in your serum sample.

Why It’s Ordered

Your healthcare provider may order this test if you have symptoms like lung inflammation (e.g., interstitial lung disease), skin rashes (e.g., dermatomyositis), or unexplained fatigue. It’s particularly useful for diagnosing rare conditions like anti-MDA5-associated interstitial lung disease (AMILD).

Sample Collection and Processing

A blood sample is drawn from a vein, typically in the arm. The serum portion is separated and tested for antibody presence using a specialized line blot assay, which detects specific protein targets.

What to Expect Before the Test

No special preparation is needed, but inform your provider if you’re taking blood thinners or have a history of bleeding disorders. Avoid alcohol or strenuous activity 24 hours before testing.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Anti-MDA5 Antibody (Serine Blot)

Frequently asked questions

Anti-MDA5 antibodies are strongly linked to a specific subtype of interstitial lung disease (AMILD) and dermatomyositis. Positive results may indicate an autoimmune response requiring further evaluation, including imaging or lung function tests, to guide treatment decisions.
This test is qualitative (detects presence/absence) or quantitative (measures antibody levels), but reference ranges vary by lab. Results may be reported as positive, negative, or indeterminate.
How long will results take? Results are typically available within 3–7 business days, depending on lab processing times.
Will this test affect my medications? No direct interactions are known, but discuss all current medications with your provider before testing.
Can I fast before this test? No fasting is required, but hydration is encouraged.
What does a positive result mean? A positive result suggests a possible autoimmune or inflammatory condition; follow-up testing (e.g., lung imaging) will help determine next steps.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy